Abstract:Newcastle disease (ND) is the most important infectious disease in poultry, which is caused by avian orthoavulavirus type 1 (AOAV-1), previously known as Newcastle disease virus (NDV). In this study, an NDV strain SD19 (GenBank accession number OP797800) was isolated, and phylogenetic analysis suggested the virus belongs to the class II genotype VII. After generating wild-type rescued SD19 (rSD19), the attenuating strain (raSD19) was generated by mutating the F protein cleavage site. To explore the potential role of the transmembrane protease, serine S1 member 2 (TMPRSS2), the TMPRSS2 gene was inserted into the region between the P and M genes of raSD19 to generate raSD19-TMPRSS2. Besides, the coding sequence of the enhanced green fluorescent protein (EGFP) gene was inserted in the same region as a control (rSD19-EGFP and raSD19-EGFP). The Western blot, indirect immunofluorescence assay (IFA), and real-time quantitative PCR were employed to determine the replication activity of these constructs. The results reveal that all the rescued viruses can replicate in chicken embryo fibroblast (DF-1) cells; however, the proliferation of raSD19 and raSD19-EGFP needs additional trypsin. We next evaluated the virulence of these constructs, and our results reveal that the SD19, rSD19, and rSD19-EGFP are velogenic; the raSD19 and raSD19-EGFP are lentogenic; and the raSD19-TMPRSS2 are mesogenic. Moreover, due to the enzymatic hydrolysis of serine protease, the raSD19-TMPRSS2 can support itself to proliferate in the DF-1 cells without adding exogenous trypsin. These results may provide a new method for the NDV cell culture and contribute to ND’s vaccine development.

Attenuation of GPMV NA-1 Strain by Reverse Genetics Technique

Construction of Reverse Genetics System of GPMV NA-1 Strain

Generation and molecular characteristics of a highly attenuated GPV strain through adaptation in GEF cells

Generation and evaluation of a recombinant genotype VII Newcastle disease virus expressing VP3 protein of Goose parvovirus as a bivalent vaccine in goslings.

Study on Infection of Avian Paramyxovirus in Goose

Development of a Reverse Genetics System Based on RNA Polymerase II for Newcastle Disease Virus Genotype VII

Establishment of Reverse Genetics for Genotype VII Newcastle Disease Virus and Altering the Cell Tropism by Inserting TMPRSS2 into the Viral Genome

HN gene's genetic variation of avain paramyxovirus-I strain NA-1 isolated from goose

Construction and Identification of the Helper Plasmids for Rescuing GPMV Strain NA-1

Evaluation of the Safety and Protection Efficacy of an Attenuated Genotype Vii Newcastle Disease Virus Strain As a Candidate Vaccine.

Virulence Identification and Attenuation of Goose Parvovirus Changzhou Strain*

Development of an improved reverse genetics system for avian metapneumovirus (aMPV): A novel vaccine vector protects against aMPV and infectious bursal disease virus

Virus-Like Particles Based on the Novel Goose Parvovirus (NGPV) VP2 Protein Protect Ducks against NGPV Challenge

The deletion of an extra six nucleotides in the 5′ -untranslated region of the nucleoprotein gene of Newcastle disease virus NA-1 decreases virulence

Development of a Novel Chimeric ND-GP Cvlps Vaccine for the Prevention of Goose-Derived Newcastle Disease and Gosling Plague

Studies on Biological Characteristics of Avian Paramyxovirus-I Strain NA-1 Isolated from Goose

Construction and identification of chimeric virus-like particles of goose parvovirus and goose paramyxovirus

Construction of the Mini-Genome of NA-1 GPMV for Rescue.

Rescue of an Enterotropic Newcastle Disease Virus Strain ZM10 from Cloned Cdna and Stable Expressing an Inserted Foreign Gene

Genetic characterization and phylogenetic analysis of Newcastle disease virus from China.

Rescue of Duck-Origin Virulent Newcastle Disease Virus from Cloned Cdna and Stable Expression of the Red Fluorescent Protein